Identifying and predicting Parkinson’s disease subtypes through trajectory clustering via bipartite networks
暂无分享,去创建一个
Michelle Girvan | Sanjukta Krishnagopal | Rainer Von Coelln | Lisa M. Shulman | M. Girvan | Sanjukta Krishnagopal | L. Shulman | R. Coelln
[1] M. DePamphilis,et al. HUMAN DISEASE , 1957, The Ulster Medical Journal.
[2] Jean-Loup Guillaume,et al. Fast unfolding of communities in large networks , 2008, 0803.0476.
[3] M E J Newman,et al. Finding and evaluating community structure in networks. , 2003, Physical review. E, Statistical, nonlinear, and soft matter physics.
[4] Kang K. L. Liu,et al. Focus on the emerging new fields of network physiology and network medicine , 2016, New journal of physics.
[5] N. Jetté,et al. The prevalence of Parkinson's disease: A systematic review and meta‐analysis , 2014, Movement disorders : official journal of the Movement Disorder Society.
[6] A. Dagher,et al. Clinical criteria for subtyping Parkinson’s disease: biomarkers and longitudinal progression , 2017, Brain : a journal of neurology.
[7] Sonja W. Scholz,et al. Identification of novel risk loci, causal insights, and heritable risk for Parkinson's disease: a meta-analysis of genome-wide association studies , 2019, The Lancet Neurology.
[8] Mason A. Porter,et al. Multilayer networks , 2013, J. Complex Networks.
[9] Stephanie A. Santorico,et al. Cluster analysis in the COPDGene study identifies subtypes of smokers with distinct patterns of airway disease and emphysema , 2014, Thorax.
[10] A. Barabasi,et al. The human disease network , 2007, Proceedings of the National Academy of Sciences.
[11] Joel S. Perlmutter,et al. Variants in GBA, SNCA, and MAPT influence Parkinson disease risk, age at onset, and progression , 2016, Neurobiology of Aging.
[12] J. Jankovic,et al. Parkinson disease subtypes. , 2014, JAMA neurology.
[13] Jean-François Gagnon,et al. New Clinical Subtypes of Parkinson Disease and Their Longitudinal Progression: A Prospective Cohort Comparison With Other Phenotypes. , 2015, JAMA neurology.
[14] R. Barker,et al. The heterogeneity of idiopathic Parkinson's disease , 2002, Journal of Neurology.
[15] T. Robbins,et al. Heterogeneity of Parkinson’s disease in the early clinical stages using a data driven approach , 2005, Journal of Neurology, Neurosurgery & Psychiatry.
[16] Albert-László Barabási,et al. A Dynamic Network Approach for the Study of Human Phenotypes , 2009, PLoS Comput. Biol..
[17] R. Barker,et al. Developing and validating Parkinson’s disease subtypes and their motor and cognitive progression , 2018, Journal of Neurology, Neurosurgery, and Psychiatry.
[18] A. Barabasi,et al. Network medicine : a network-based approach to human disease , 2010 .
[19] L. Shulman,et al. Clinical subtypes and genetic heterogeneity: of lumping and splitting in Parkinson disease. , 2016, Current opinion in neurology.
[20] Jose A. Santiago,et al. A network approach to clinical intervention in neurodegenerative diseases. , 2014, Trends in molecular medicine.
[21] Houeto Jean-Luc. [Parkinson's disease]. , 2022, La Revue du praticien.
[22] S. Fereshtehnejad,et al. Subtypes of Parkinson’s Disease: What Do They Tell Us About Disease Progression? , 2017, Current Neurology and Neuroscience Reports.
[23] A. Rajput,et al. Baseline motor findings and Parkinson disease prognostic subtypes , 2017, Neurology.
[24] A. Lang,et al. Parkinson's disease subtypes: lost in translation? , 2012, Journal of Neurology, Neurosurgery & Psychiatry.
[25] J. Loscalzo,et al. The Emerging Paradigm of Network Medicine in the Study of Human Disease , 2012, Circulation research.
[26] L. Wilkins. Genetic risk of Parkinson disease and progression: An analysis of 13 longitudinal cohorts , 2019, Neurology: Genetics.
[27] Mason A. Porter,et al. Community Detection in Temporal Multilayer Networks, with an Application to Correlation Networks , 2014, Multiscale Model. Simul..
[28] T. Montine,et al. Common variant rs356182 near SNCA defines a Parkinson's disease endophenotype , 2016, Annals of clinical and translational neurology.
[29] M. Vidal,et al. Networking metabolites and diseases , 2008, Proceedings of the National Academy of Sciences.
[30] A. Barabasi,et al. Controllability analysis of the directed human protein interaction network identifies disease genes and drug targets , 2015, Proceedings of the National Academy of Sciences.
[31] D. Hernandez,et al. Genomewide association study of Parkinson's disease clinical biomarkers in 12 longitudinal patients' cohorts , 2019, Movement disorders : official journal of the Movement Disorder Society.
[32] Jean-Pierre Bouchard,et al. Replication study of MATR3 in familial and sporadic amyotrophic lateral sclerosis , 2016, Neurobiology of Aging.
[33] Siddique Latif,et al. Community detection in networks: A multidisciplinary review , 2018, J. Netw. Comput. Appl..